Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases
BackgroundPapillary thyroid cancer (PTC) in clinically lymph node-negative (cN0) patients is prone toward lymph node metastasis. As a risk factor for tumor persistence and local recurrence, lateral lymph node metastasis (LLNM) is related to the number of central lymph node metastases (CLNMs).Methods...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.716728/full |
_version_ | 1819009060789288960 |
---|---|
author | Yuanyuan Wang Chang Deng Xiujie Shu Ping Yu Huaqiang Wang Xinliang Su Jinxiang Tan |
author_facet | Yuanyuan Wang Chang Deng Xiujie Shu Ping Yu Huaqiang Wang Xinliang Su Jinxiang Tan |
author_sort | Yuanyuan Wang |
collection | DOAJ |
description | BackgroundPapillary thyroid cancer (PTC) in clinically lymph node-negative (cN0) patients is prone toward lymph node metastasis. As a risk factor for tumor persistence and local recurrence, lateral lymph node metastasis (LLNM) is related to the number of central lymph node metastases (CLNMs).MethodsWe performed LLNM risk stratification based on the number of CLNMs for cN0 PTC patients who underwent thyroidectomy and lymph node dissection between January 2013 and December 2018. A retrospective analysis was applied to the 274 collected patients with 1-2 CLNMs. We examined the clinicopathological characteristics of the patients and constructed a LASSO model.ResultsIn the 1–2 CLNM group, tumors >10 mm located in the upper region and nodular goiters were independent risk factors for LLNM. Specifically, tumors >20 mm and located in the upper region contributed to metastasis risk at level II. Hashimoto’s thyroiditis reduced this risk (p = 0.045, OR = 0.280). Age ≤ 30 years and calcification (microcalcification within thyroid nodules) correlated with LLNM. The LASSO model divided the population into low- (25.74%) and high-risk (57.25%) groups for LLNM, with an AUC of 0.715.ConclusionsFor patients with 1–2 CLNMs, young age, calcification, nodular goiter, tumor >10 mm, and tumor in the upper region should alert clinicians to considering a higher occult LLNM burden. Close follow-up and therapy adjustment may be warranted for high-risk patients. |
first_indexed | 2024-12-21T00:50:22Z |
format | Article |
id | doaj.art-cdb041c2b79e4db7a4f8a248efd1ce98 |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-12-21T00:50:22Z |
publishDate | 2021-10-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-cdb041c2b79e4db7a4f8a248efd1ce982022-12-21T19:21:25ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-10-011210.3389/fendo.2021.716728716728Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node MetastasesYuanyuan Wang0Chang Deng1Xiujie Shu2Ping Yu3Huaqiang Wang4Xinliang Su5Jinxiang Tan6Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Hepatobiliary, Breast and Thyroid Surgery, The People’s Hospital of Nanchuan, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaBackgroundPapillary thyroid cancer (PTC) in clinically lymph node-negative (cN0) patients is prone toward lymph node metastasis. As a risk factor for tumor persistence and local recurrence, lateral lymph node metastasis (LLNM) is related to the number of central lymph node metastases (CLNMs).MethodsWe performed LLNM risk stratification based on the number of CLNMs for cN0 PTC patients who underwent thyroidectomy and lymph node dissection between January 2013 and December 2018. A retrospective analysis was applied to the 274 collected patients with 1-2 CLNMs. We examined the clinicopathological characteristics of the patients and constructed a LASSO model.ResultsIn the 1–2 CLNM group, tumors >10 mm located in the upper region and nodular goiters were independent risk factors for LLNM. Specifically, tumors >20 mm and located in the upper region contributed to metastasis risk at level II. Hashimoto’s thyroiditis reduced this risk (p = 0.045, OR = 0.280). Age ≤ 30 years and calcification (microcalcification within thyroid nodules) correlated with LLNM. The LASSO model divided the population into low- (25.74%) and high-risk (57.25%) groups for LLNM, with an AUC of 0.715.ConclusionsFor patients with 1–2 CLNMs, young age, calcification, nodular goiter, tumor >10 mm, and tumor in the upper region should alert clinicians to considering a higher occult LLNM burden. Close follow-up and therapy adjustment may be warranted for high-risk patients.https://www.frontiersin.org/articles/10.3389/fendo.2021.716728/fullcN0PTCLLNMCLNMLASSO |
spellingShingle | Yuanyuan Wang Chang Deng Xiujie Shu Ping Yu Huaqiang Wang Xinliang Su Jinxiang Tan Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases Frontiers in Endocrinology cN0 PTC LLNM CLNM LASSO |
title | Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases |
title_full | Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases |
title_fullStr | Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases |
title_full_unstemmed | Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases |
title_short | Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1–2 Central Lymph Node Metastases |
title_sort | risk factors and a prediction model of lateral lymph node metastasis in cn0 papillary thyroid carcinoma patients with 1 2 central lymph node metastases |
topic | cN0 PTC LLNM CLNM LASSO |
url | https://www.frontiersin.org/articles/10.3389/fendo.2021.716728/full |
work_keys_str_mv | AT yuanyuanwang riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases AT changdeng riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases AT xiujieshu riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases AT pingyu riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases AT huaqiangwang riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases AT xinliangsu riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases AT jinxiangtan riskfactorsandapredictionmodeloflaterallymphnodemetastasisincn0papillarythyroidcarcinomapatientswith12centrallymphnodemetastases |